Aug. 24, 2016 – Great China International Holdings, Inc. (Stock Code: GCIH), a company engaged in real estate and producing green and healthcare foods (drugs) with biotechniques through core business transition announced that its name changed to HH Biotechnology Holdings Company, effective on August 24, 2016.
‘We wanted our name to describe our company's direction and objectives more accurately,’ said Frank Jiang, Chairman and CEO. 'Our recent investment into Sino-Australian Agricultural Technology, an agricultural developer in China that occupies the world's largest contiguous acreage base for Macadamia nut planting, was a major step in our plan to focus on the health and green industries and supplying nutritional products to an increasingly health-concerned population in China and around the world, and we believe that the name HH Biotechnology Holdings Corporation better reflects our long-term strategy and identity for the health and green industries.'

For additional information on the name change, please see the Information Statement filed with the Securities and Exchange Commission on July 28, 2018, and mailed to stockholders the following day.  Also, please follow the Company at its new website at http: //hhbiotechnology.com.

Note: Outstanding stock certificates will represent the same stock ownership in the Company after the name change, and it's not necessary for the stockholders to exchange stock certificates with the former name of the Company for stock certificates with the new name.

About HH Biotechnology Holdings Company

HH Biotechnology Holdings Company's primary Chinese subsidiary was founded in 1989, and has been involved in various businesses from cultural industries to real estate development, agricultural plantation and biotechnology. For more information, please go to http://hhbiotechnology.com.

Forward-looking statement:
This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For a more complete discussion of such risks and uncertainties, please refer to the company's filings with the Securities and Exchange Commission.

Media Contact:  Phil Case
Fluid Advertising
801.362.9991
phil@getfluid.com